Skip to content

MDMA research published in 2004

Page 3 of 3: studies 41 to 55 of 55, newest first. Back to the MDMA overview

Studies

Methamphetamine and MDMA (Ecstasy) Neurotoxicity: 'of Mice and Men'

IUBMB Life May 1, 2004 Yossef Itzhak, Cindy Achat‐mendes 60 citations

Abstract Methamphetamine (METH) and 3,4‐meythylenedioxymethamphetamine (MDMA; 'ecstasy') are currently major drugs of abuse. One of the major concerns of amphetamines abuse is their potential neurotoxic effect on dopaminergic and serotonergic neurons. Although data from human studies are somewhat limited, compelling evidence suggests that these drugs cause neurotoxicity in rodents and primates....

Metabolism Is Required for the Expression of Ecstasy-Induced Cardiotoxicity in Vitro

Chemical Research in Toxicology April 27, 2004 Márcia Carvalho, Fernando Remião, Nuno Milhazes et al. 77 citations

Cardiovascular complications associated with 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) abuse have increasingly been reported. The indirect effect of MDMA mediated by a sustained high level of circulating biogenic amines may contribute to the cardiotoxic effects, but other factors, like the direct toxic effects of MDMA and its metabolites in cardiac cells, remain to be investigated....

DOI: 10.1021/tx049960f (opens in new tab) MDMA Ecstasy Glutathione reductase Pharmacology +6

MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission.

FEBS Letters April 9, 2004 Rabi Simantov, Weiping Peng

In several countries, 3,4-methylenedioxymethamphetamine (MDMA) is currently the most abundant psychoactive recreational drug. MDMA induces numerous neuropsychiatric behaviors, serotonergic neuron degeneration, programmed death of cultured cells, hyperthermia and occasional fatality. Using gene expression analysis in MDMA-treated mice, we identified changes in gamma-amino butyric acid (GABA)...

Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): a stressor on the immune system

Immunology March 30, 2004 Thomas J. Connor 101 citations

Summary Drug abuse is a global problem of considerable concern to health. One such health concern stems from the fact that many drugs of abuse have immunosuppressive actions and consequently have the potential to increase susceptibility to infectious disease. This article is focused on the impact of the amphetamine derivative, methylenedioxymethamphetamine (MDMA; ‘Ecstasy’) on immunity....

Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types

Therapeutic Drug Monitoring March 19, 2004 Hans H Maurer, Thomas Kræmer, Dietmar Springer et al. 147 citations

Designer drugs of the amphetamine type (eg, MDMA, MDEA, MDA), of the new benzyl or phenyl piperazine type (eg, BZP, MDBP, mCPP, TFMPP, MeOPP), or of the pyrrolidinophenone type (eg, PPP, MOPPP, MDPPP, MPPP, MPHP) have gained popularity and notoriety as rave drugs. These drugs produce feelings of euphoria and energy and a desire to socialize. Although in the corresponding drug scene designer...

The Role of Metabolism in 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylenedioxymethamphetamine (Ecstasy) toxicity

Therapeutic Drug Monitoring March 19, 2004 Terrence J. Monks, Douglas C. Jones, Fengju Bai et al. 123 citations

3,4-Methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are ring-substituted amphetamine derivatives with stimulant and hallucinogenic properties. The recreational use of these amphetamines, especially MDMA, is prevalent despite warnings of irreversible damage to the central nervous system. MDA and MDMA are primarily serotonergic neurotoxicants. Because (1)...

Human Pharmacology of MDMA

Therapeutic Drug Monitoring March 19, 2004 Rafael de la Torre, Magı́ Farré, Pere N. Roset et al. 445 citations

MDMA (3,4-methylenedioxymethamphetamine, ecstasy) is a widely misused psychostimulant drug abused among large segments of the young population. Pharmacologically it displays effects related to amphetamine-type drugs and a set of distinctive effects (closeness to others, facilitation to interpersonal relationship, and empathy) that have been named by some authors "entactogen" properties. MDMA is...

Validação de método para determinação de 3,4-metilenodioximetanfetamina (MDMA) em comprimidos de ecstasy por cromatografia em fase gasosa

Revista Brasileira de Ciências Farmacêuticas March 1, 2004 Silvio Fernandes Lapachinske, Maurı́cio Yonamine, Regina Lúcia de Moraes Moreau 6 citations

O ecstasy é comercializado, de maneira ilegal, normalmente sob a forma de comprimidos, com cores, aspectos, dimensões e logotipos variados. Quimicamente, é a metilenodioximetanfetamina (MDMA), um composto sintético com propriedades estimulante central e alucinogênicas. Devido à grande expansão do abuso de ecstasy, também tem aumentado o número de casos de intoxicações, decorrentes diretamente...

Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys

Behavioural Pharmacology March 1, 2004 William E Fantegrossi, James H Woods, Gail Winger 99 citations

Relatively few studies have assessed the reinforcing effects of hallucinogenic compounds, and no such studies have attempted to engender contingent responding for these compounds in animals with behavioral histories that include experience with serotonergically mediated reinforcing effects. The objectives of the present study were to investigate the capacity of several hallucinogenic compounds...

Hyperkalemia in fatal MDMA ('ecstasy') toxicity.

International journal of cardiology February 2004 Paula Raviña, Jose Maria Quiroga, Tomas Raviña

3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') is an amphetamine synthetic analog widely used as an recreational drug. Acute and severe toxic effects following MDMA ingestion include hyperthermia, arrhythmias, rhabdomyolisis, disseminated intravascular coagulation, hepatotoxicity and even death. Recently, we treated a patient in whom hyperkalemia, in the absence of renal failure,...

Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use

Psychological Medicine January 28, 2004 Karen L. Hanson, Mónica Luciana 71 citations

Background. Use of MDMA (ecstasy), a serotonin neurotoxin, has been associated with memory impairment and psychological dysfunction. This study examined cognitive functioning in abstinent MDMA users and MDMA-naïve controls. Method. Participants completed measures of intelligence, motor function, attention, memory span, verbal fluency, immediate and delayed verbal memory, and working memory....

Multiple molecular and neuropharmacological effects of MDMA (Ecstasy).

Life Sciences January 2, 2004 Rabi Simantov

3,4-Methylenedioxymethamphetamine (MDMA), commonly referred to as Ecstasy, is a widely abused, psychoactive recreational drug, which induces short- and long-term neuropsychiatric behaviors. This drug is neurotoxic to serotonergic neurons in vivo, and induces programmed cell death in cultured human serotonergic cells and rat neocortical neurons. Over the years it has been shown that MDMA alters...

The Varieties of Ecstasy Experience (Sean Leneghan)

Dancecult 2004 Daniel Paul Schnee

An absolute insider of the international underground electronic music scene for 20 years or so, Riccardo Balli is the best conceivable Charon for those who weren't there and want to get at least a flavour of what it was-and still is-all about. But beware, Balli is neither a music critic nor a music historian. Rather, a DJ, label owner, composer, novelist, live performer and, above all, a...

MDMA (3,4-Methylenedioxymethamphetamine) or Ecstasy: The Neuropsychobiological Implications of Taking It at Dances and Raves

Neuropsychobiology 2004 A. C. Parrott 152 citations

MDMA (3,4-methylenedioxymethamphetamine) or ‘ecstasy’ is a ring-substituted amphetamine derivative, which is widely used as a recreational drug, most particularly at dances and raves. Around 80–95% of dancers/ravers report using ecstasy/MDMA, compared to 5–15% of young people in general. This paper will consider the possible contribution of stimulatory environmental conditions to the...

Ocular sequelae from the illicit use of class A drugs

British and Irish Orthoptic Journal 2004 Alison Firth 13 citations

Aim: To highlight the changes that may take place in the visual system of the class A drug abuser.Methods: A literature review was carried out of ocular/visual sequelae of the more common class A drugs. These include stimulants (cocaine and crack cocaine), narcotics (heroin, morphine, methadone) and hallucinogenics (ecstasy, lysergic acid diethylamide, magic mushrooms, mescaline,...